• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC | Inspections
 


New Search Back to Search Results
Note: this medical device record is a supplement. The device description may have changed. Be sure to look at the original PMA to get an up-to-date view of this device.
 
Trade NameSOFLENS (POLYMACON) CONTACT LENSES
Classification Namelenses, soft contact, extended wear
Generic Namesoft contact lens
Regulation Number886.5925
ApplicantBAUSCH & LOMB, INC.
PMA NumberN16895
Supplement NumberS084
Date Received10/01/1996
Decision Date01/30/1997
Product Code
LPM[ Registered Establishments with LPM ]
Advisory Committee Ophthalmic
Supplement Typenormal 180 day track
Supplement Reason labeling change - instructions
Expedited Review Granted? No
Combination Product No
Approval Order Statement 
Approval for labeling modifictions to soflens(r) (polymacon) contact lenses including the following lens types (series): 03, 04, occasions(tm) multifocal, optima(tm) 38, optima(tm) 38/sp, u3, u4, sofspin(tm), h03, h04, b3, b4, p. A. 1, f3, h3, h4, n, naturaltine, optima(tm) fw, and seequence(tm). Modifications include: 1)removing the replacement system descriptors from labeling specific to the optima(tm) fw contact lenses; 2)adding monovisio fitting technique for all bausch & lomb soflens(r) (polymacon) contact lenses in this supplement;3)consolidating info in six fitting guides into 3 fitting guides for soflens(r), naturaltint(r), occasions(tm) multifocal, and p. A. 1 contact lenses; 4)consolidating 2 patient info booklets (1 for frequent replacement use and 1 for disposable use) for seequence(tm) (polymacon) visibility tinted contact lenses into a single patient info booklet (this modification results in deletion of the disposable wear indication); 5)formatting changes to package inserts, fitting fuides & patient info booklets to bring labeling up-to-date with recommendations in cdrh's current labeling guidance; and 6)separating the therapeutic indiation from the cosmetic labeling included in this supplement.
-
-